October 24th 2024
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
Community pharmacists rally on Capitol Hill
May 24th 2011The National Community Pharmacists Association Conference taking place May 23 to May 25 in Washington, D.C., at the Hyatt Regency on Capitol Hill is focusing on how the expert medication counseling and new, nontraditional services provided by local pharmacists can help reduce costs and improve patient outcomes.
Proton pump inhibitors linked to fracture risk
May 24th 2011Proton pump inhibitors are associated with a 29% increased risk of fracture, including a 31% increased risk of hip fracture and a 54% increased risk of vertebral fracture, according to a study published in the May/June 2011 issue of Annals of Family Medicine.
Most NSAIDs unsafe for patients with prior MI
May 24th 2011There is no safe therapeutic window of time for using NSAIDs in patients with prior myocardial infarction. Even short-term treatment with most NSAIDs appears associated with increased risk of death and recurrent MI, reported a study published in Circulation.
Late-breaking news: FDA approves Sutent for advanced pancreatic neuroendocrine tumors
May 23rd 2011FDA has approved sunitinib malate (Sutent, Pfizer) as the first anti-vascular endothelial growth factor therapy to treat progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.
Late-breaking news: FDA approves rilpivirine for HIV-1 infection in treatment-naïve adults
May 20th 2011FDA has approved rilpivirine (Edurant, Tibotec Therapeutics, a division of Centocor Ortho Biotech) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy.
Breaking News: REMS now available for Avandia; access to drug restricted
May 19th 2011FDA announced May 18 to the public new restrictions to the prescribing, dispensing, and use of rosiglitazone-containing medications (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline [GSK]) as part of a Risk Evaluation and Mitigation Strategy.
Diabetes, specialty drugs continue to drive growth in drug spending
May 18th 2011For the fourth consecutive year, diabetes therapy topped the list of contributors to drug use trends in therapeutic categories, contributing 16.1% to overall growth in drug spending in 2010 due to an increasing number of patients, according to the recently released 2011 Medco Drug Trend Report, which tracks utilization and spending.
Late-breaking news: FDA approves boceprevir for hepatitis C
May 17th 2011FDA has approved boceprevir (Victrelis, Merck) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients aged 18 years and older with compensated liver disease.
Improved REMS programs are focus of white paper
May 17th 2011APhA's white paper focusing on improving REMS programs and designing a system that maximizes patient safety while minimizing burdens on the healthcare system was published in the May/June issue of the Journal of the American Pharmacists Association.
NACDS chairman urges “active diligence” in engaging lawmakers
May 17th 2011Richard D. Loeffler stressed the pressing need for ?active diligence? in engaging with federal and state lawmakers in his inaugural address as chairman of the NACDS board of directors at the organization?s recent annual meeting.
FDA holds corporate execs responsible for pharma abuses
May 15th 2011Frustrated by its lack of success at reining in drug-company abuses, FDA is bringing back a legal doctrine spawned by long-dead rodents to bring criminal charges against pharmaceutical executives, including executives who had no personal knowledge of company misdeeds.
Pharmacy school loan forgiveness: Healthcare reform offers students new hope
May 15th 2011If the Affordable Care Act makes pharmacists primary care providers, the profession gains a host of advantages, including Medicare provider status. For AACP, the goal is eligibility for student loan forgiveness under the NHSC.